Abstract
HOPING TO REDUCE unnecessary medical treatment and strengthen the detection of disease outbreaks, an expert panel has recommended widespread culturing of laboratory specimens for Escherichia coli O157:H7. The panel, sponsored by the American Gastroenterological Association Foundation, met last month in Washington, DC. After hearing testimony from experts in medicine, public health, the food industry, and federal regulatory agencies, the panel produced a report with recommendations to stem "a major national problem." Who's Getting Sick, and Why? From 1982, when the virulent O157:H7 strain was identified as a human pathogen, through 1992, only two to three outbreaks were investigated each year in the United States. The figure jumped to 16 in 1993; 11 outbreaks during the first half of this year are being studied. Some of the increase is attributed to growing awareness, but the panel said the actual number of infections appears to be rising. It is estimated that E
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: JAMA: The Journal of the American Medical Association
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
